Talk:Radiopharmacology: Difference between revisions
Content deleted Content added
Line 6: | Line 6: | ||
The article on [[astatine]] mentions the uses of this element, particularly treating cancer; why then is it not mentioned as a radiopharmaceutical?[[Special:Contributions/24.184.234.24|24.184.234.24]] ([[User talk:24.184.234.24|talk]]) 02:05, 15 June 2010 (UTC)LeucineZipper |
The article on [[astatine]] mentions the uses of this element, particularly treating cancer; why then is it not mentioned as a radiopharmaceutical?[[Special:Contributions/24.184.234.24|24.184.234.24]] ([[User talk:24.184.234.24|talk]]) 02:05, 15 June 2010 (UTC)LeucineZipper |
||
Is the problem its not being approved in humans currently?[[Special:Contributions/24.184.234.24|24.184.234.24]] ([[User talk:24.184.234.24|talk]]) 02:08, 15 June 2010 (UTC)LeucineZipper |
Revision as of 02:09, 15 June 2010
Medicine B‑class Mid‑importance | ||||||||||
|
Pharmacology B‑class | ||||||||||
|
The article on astatine mentions the uses of this element, particularly treating cancer; why then is it not mentioned as a radiopharmaceutical?24.184.234.24 (talk) 02:05, 15 June 2010 (UTC)LeucineZipper Is the problem its not being approved in humans currently?24.184.234.24 (talk) 02:08, 15 June 2010 (UTC)LeucineZipper